Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;16(6):539-47.
doi: 10.1007/s12094-013-1115-0. Epub 2013 Oct 2.

High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma

T Yu  1 , Z Wang, K Liu, Y Wu, J Fan, J Chen, C Li, G Zhu, L Li
Affiliations

High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma

T Yu et al. Clin Transl Oncol. 2014 Jun.

Abstract

Objective: The present study was carried out to analyze the interstitial fluid pressure (IFP) values in patients with oral squamous cell carcinoma and identify the relationship between the IFP and tumor prognosis.

Methods: We investigated tumor lymphatic metastasis-related protein (VEGFC, VEGFD and VEGFR3) expressions change on SCC-4 and SCC-9 cells subjected to increased extracellular pressure in vitro and analyzed the relationship between these proteins and IFP, and prognosis of patients with oral squamous cell carcinoma.

Results: The results showed that the elevated extracellular pressure significantly resulted in a dramatic increase of VEGFC, VEGFD and VEGFR3 protein expressions in OSCC. More important, the activation of VEGFC, VEGFD and VEGFR3 proteins through IFP elevation contributed to poor prognosis for patients with OSCC.

Conclusions: These results suggest an important potential clinical application of measuring IFP, which can be used as a generic marker of prognosis evaluation and response to therapy. Furthermore, VEGFC, VEGFD and VEGFR3 may be useful targets in developing novel and specific therapeutic tool for OSCC patients with high IFP.

PubMed Disclaimer

References

    1. Oral Oncol. 2003 Jun;39(4):391-6 - PubMed
    1. Radiother Oncol. 2006 Aug;80(2):132-7 - PubMed
    1. Cancer Res. 2001 Sep 1;61(17):6400-5 - PubMed
    1. Cancer Res. 1992 Apr 1;52(7):1993-5 - PubMed
    1. Cancer Res. 2002 Feb 1;62(3):661-4 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources